BUPA completes Health Dialog purchase

Health Dialog announced today that BUPA, its largest shareholder, will purchase for cash the equity in the company it does not already own.

The transaction values Health Dialog at $775 million, said Health Dialog, a Boston company that provides care management services, including disease management.

Headquartered in London, BUPA is a provider of private healthcare-related services in the United Kingdom.

“Being a part of BUPA will permit us to accelerate our growth,” George Bennett, chairman and chief executive of Health Dialog, said in a statement.
(By Chris Reidy, Globe staff)